Androgen Deprivation Therapy trials for Prostate Cancer Metastatic

All Androgen Deprivation Therapy trials · All Prostate Cancer Metastatic trials

Phase breakdown

Recruiting trials studying Androgen Deprivation Therapy for Prostate Cancer Metastatic

• ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
  NCT04916613 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 95 locations
• Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
  NCT04983095 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 7 locations
• Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
  NCT05352178 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study Androgen Deprivation Therapy for Prostate Cancer Metastatic?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.